Orsero (ORS) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
13 Mar, 2026Executive summary
FY 2025 results exceeded guidance, with all geographies, product lines, and legal entities profitable, driven by strong Distribution BU growth and record Shipping BU loading factors.
Net sales reached €1,700.6 million, up 8.2% year-over-year, with adjusted EBITDA at €86.9 million (+3.8%) and adjusted net profit at €33.0 million (+4.7%).
Operating cash flow remained robust, supporting investments, a solid financial structure, and dividend distribution.
All ESG and sustainability targets were met or exceeded, involving 100% of market stands, employees, and warehouses.
Dividend proposal of €0.61 per share (cash and shares) to be approved at the next AGM.
Financial highlights
Net sales rose to €1,700.6 million, up €129.3 million (+8.2%) year-over-year, surpassing guidance.
Adjusted EBITDA was €86.9 million (+3.8%), with a margin of 5.1%; adjusted net profit reached €33.0 million (+4.7%).
Reported net profit was €30.0 million (+8.3%).
Net financial position (NFP) including IFRS 16 was €116.1 million; excluding IFRS 16, €49.7 million.
Proposed dividend of €0.61 per share (yield 3.2%), with €0.50 in cash and €0.11 in shares.
Outlook and guidance
FY 2025 results outperformed revised guidance for net sales, adjusted EBITDA, and adjusted net profit.
FY 2026 guidance: net sales €1,700–1,740 million, adjusted EBITDA €78–83 million, adjusted net profit €25–29 million, CAPEX €14–16 million.
Continued focus on high value-added products and organic/external growth, with investments planned.
No revision or suspension of guidance despite macroeconomic and geopolitical uncertainties; business model considered robust.
Slight compression in shipping profitability expected due to operational issues, not market deterioration.
Latest events from Orsero
- Double-digit revenue and profit growth in H1 2025 led to an upward revision of FY guidance.ORS
Q2 20253 Feb 2026 - Net sales and EBITDA declined, but Q2 Distribution outperformed and cash flow stayed robust.ORS
H1 202420 Jan 2026 - Stable revenues and strong distribution offset profit decline; FY 2024 guidance confirmed.ORS
Q3 202413 Jan 2026 - 2024 targets met with resilient high-value growth and strong cash flow, despite margin pressure.ORS
Q4 202426 Dec 2025 - Q1 2025 net sales up 12.6%, EBITDA up 28%, guidance and dividend confirmed.ORS
Q1 202526 Nov 2025 - Strong revenue and profit growth in 9M 2025, with guidance confirmed at the upper end.ORS
Q3 202514 Nov 2025